New horizons for stem cell therapy in liver disease

Journal of Hepatology

Volumn 56, Issue 2, 2012, Pages 496-499

  Forbes, Stuart J ^a   Newsome, Philip N ^b,c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cell therapy; Liver disease; Stem cell

Indexed keywords

CD133 ANTIGEN; CELL THERAPY AGENT; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ALCOHOL LIVER DISEASE; ARTERY DISSECTION; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL PROLIFERATION; CHILD PUGH SCORE; DOWN REGULATION; EMBRYONIC STEM CELL; END STAGE LIVER DISEASE; GRAFT VERSUS HOST REACTION; HEPATIC ARTERY DISSECTION; HEPATIC PROGENITOR CELL; HEPATOCYTE LIKE CELL; HUMAN; IMMUNE MEDIATED INJURY; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER METASTASIS; LIVER REGENERATION; LIVER TRANSPLANTATION; MACROPHAGE; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SINGLE DRUG DOSE; STEM CELL; STEM CELL TRANSPLANTATION;

EID: 84855954616     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.06.022     Document Type: Note

References (27)

1. D.D. Houlihan, and P.N. Newsome Critical review of clinical trials of bone marrow stem cells in liver disease Gastroenterology 135 2008 438 450
2. Y.N. Kallis, A.J. Robson, J.A. Fallowfield, H.C. Thomas, M.R. Alison, and N.A. Wright Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response Gut 60 2011 525 533
3. I. Sakaida, S. Terai, N. Yamamoto, K. Aoyama, T. Ishikawa, and H. Nishina Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice Hepatology 40 2004 1304 1311 (Pubitemid 39657004)
4. G. Furst, J. Schulte am Esch, L.W. Poll, S.B. Hosch, L.B. Fritz, and M. Klein Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience Radiology 243 2007 171 179 (Pubitemid 46579708)
5. J.S. Duffield, S.J. Forbes, C.M. Constandinou, S. Clay, M. Partolina, and S. Vuthoori Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair J Clin Invest 115 2005 56 65 (Pubitemid 40385505)
6. J.A. Thomas, C. Pope, D. Wojtacha, A.J. Robson, T.T. Gordon-Walker, and S. Hartland Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration and function Hepatology 53 2011 2003 2015
7. T. Nakamura, T. Torimura, M. Sakamoto, O. Hashimoto, E. Taniguchi, and K. Inoue Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model Gastroenterology 133 2007 91 107
8. F.P. Russo, M.R. Alison, B.W. Bigger, E. Amofah, A. Florou, and F. Amin The bone marrow functionally contributes to liver fibrosis Gastroenterology 130 2006 1807 1821 (Pubitemid 43668827)
9. S. Terai, T. Ishikawa, K. Omori, K. Aoyama, Y. Marumoto, and Y. Urata Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy Stem Cells 24 2006 2292 2298 (Pubitemid 44527483)
10. H. Aurich, M. Sgodda, P. Kaltwasser, M. Vetter, A. Weise, and T. Liehr Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo Gut 58 2009 570 581
11. T.K. Kuo, S.P. Hung, C.H. Chuang, C.T. Chen, Y.R. Shih, and S.C. Fang Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells Gastroenterology 134 2008 2111 2121
12. A.B. Carvalho, L.F. Quintanilha, J.V. Dias, B.D. Paredes, E.G. Mannheimer, and F.G. Carvalho Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury Stem Cells 26 2008 1307 1314
13. P. Sancho-Bru, M. Najimi, M. Caruso, K. Pauwelyn, T. Cantz, and S. Forbes Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside? Gut 58 2009 594 603
14. G. Ren, L. Zhang, X. Zhao, G. Xu, Y. Zhang, and A.I. Roberts Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide Cell Stem Cell 2 2008 141 150 (Pubitemid 351181031)
15. C.D. Wan, R. Cheng, H.B. Wang, and T. Liu Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model Hepatobiliary Pancreat Dis Int 7 2008 29 33 (Pubitemid 351247053)
16. P. Kebriaei, L. Isola, E. Bahceci, K. Holland, S. Rowley, and J. McGuirk Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease Biol Blood Marrow Transplant 15 2009 804 811
17. R.S. Waterman, S.L. Tomchuck, S.L. Henkle, and A.M. Betancourt A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype PLoS ONE 5 2010 e10088
18. P. Kharaziha, P.M. Hellstrom, B. Noorinayer, F. Farzaneh, K. Aghajani, and F. Jafari Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial Eur J Gastroenterol Hepatol 21 2009 1199 1205
19. B.G. Couto, R.C. Goldenberg, L.M. da Fonseca, J. Thomas, B. Gutfilen, and C.M. Resende Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study Liver Int 31 2011 391 400
20. H. Salama, A.R. Zekri, A.A. Bahnassy, E. Medhat, H.A. Halim, and O.S. Ahmed Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease World J Gastroenterol 16 2010 5297 5305
21. A.C. Lyra, M.B. Soares, L.F. da Silva, E.L. Braga, S.A. Oliveira, and M.F. Fortes Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study Eur J Gastroenterol Hepatol 22 2010 33 42
22. P.N. Newsome, I. Johannessen, S. Boyle, E. Dalakas, K.A. McAulay, and K. Samuel Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion Gastroenterology 124 2003 1891 1900 (Pubitemid 36666784)
23. D.C. Hay, J. Fletcher, C. Payne, J.D. Terrace, R.C. Gallagher, and J. Snoeys Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling Proc Natl Acad Sci USA 105 2008 12301 12306
24. S.T. Rashid, S. Corbineau, N. Hannan, S.J. Marciniak, E. Miranda, and G. Alexander Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells J Clin Invest 120 2010 3127 3136
25. G.J. Sullivan, D.C. Hay, I.H. Park, J. Fletcher, Z. Hannoun, and C.M. Payne Generation of functional human hepatic endoderm from human induced pluripotent stem cells Hepatology 51 2010 329 335
26. J. Jozefczuk, A. Prigione, L. Chavez, and J. Adjaye Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation Stem Cells Dev 20 2011 1259 1275
27. M. Inamura, K. Kawabata, K. Takayama, K. Tashiro, F. Sakurai, and K. Katayama Efficient generation of hepatoblasts from human ES cells and iPS cells by transient overexpression of homeobox gene HEX Mol Ther 19 2011 400 407